RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...

The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...

Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

While ART can suppress the virus, it cannot cure HIV and requires life-long adherence ... Because these bNAbs are expected to remain in the body for many months, participants who have HIV-1 RNA 200 ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible ...

“By understanding how the virus cleverly manipulates our cells ... Grant VH-NG-1347 and the Center for Structural Biology of HIV-1 RNA U54 AI170660. Helmholtz Institute for RNA-based Infection ...